Tokyo Tape
Sign in
← Em Systems

Quarterly report · Q2

4820.TEDINET S100OY0R
Period2022-01-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥8.2bn2022-01-01 → 2022-06-30Cons.Net sales
Revenue¥14.4bn2021-01-01 → 2021-12-31Cons.Net sales (5-year summary)
Revenue¥6.7bn2021-01-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-01-01 → 2022-06-30Cons.Operating income
Operating income¥582m2021-01-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.6bn2022-01-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥2.6bn2021-01-01 → 2021-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2021-01-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.6bn2022-01-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥1.0bn2021-01-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.8bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥687m2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss
Net income¥679m2021-01-01 → 2021-06-30Cons.Profit loss
Total assets¥24.8bnat 2022-06-30Cons.Assets
Total assets¥24.8bnat 2021-12-31Cons.Assets
Total assets¥23.6bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2022-06-30Cons.Liabilities
Total liabilities¥6.0bnat 2021-12-31Cons.Liabilities
Net assets / equity¥19.1bnat 2022-06-30Cons.Net assets
Net assets / equity¥18.8bnat 2021-12-31Cons.Net assets
Net assets / equity¥17.9bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥8.4bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥8.3bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥8.4bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.3bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥7.3bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.0bnat 2020-12-31dCons.Cash and cash equivalents
Operating cash flow¥1.3bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.7bn2021-01-01 → 2021-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥760m2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥295m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥544m2021-01-01 → 2021-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥831m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥876m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥693m2021-01-01 → 2021-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥400m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥15.352022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.422022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.722021-01-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥9.682021-01-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.462021-04-01 → 2021-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥15.312022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥25.642021-01-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥9.652021-01-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio76.6%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio75.5%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio75.4%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30¥15m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥55m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥184m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥347m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥328m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥19m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥22m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥5m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥1.5bn
—segment totalrevenue2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue intersegment2022-01-01 → 2022-06-30¥24m
—segment totalsegment profit2022-01-01 → 2022-06-30¥1.3bn
Reconciling Itemsreconcilingrevenue2021-01-01 → 2021-06-30−¥6m
Reconciling Itemsreconcilingrevenue intersegment2021-01-01 → 2021-06-30−¥6m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-06-30¥15m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥303m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥303m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥4m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥920m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥920m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥16m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥356m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥351m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2021-01-01 → 2021-06-30¥5m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2021-01-01 → 2021-06-30−¥11m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2021-01-01 → 2021-06-30¥5.1bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2021-01-01 → 2021-06-30¥5.1bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2021-01-01 → 2021-06-30¥1m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2021-01-01 → 2021-06-30¥591m
—segment totalrevenue2021-01-01 → 2021-06-30¥6.7bn
—segment totalrevenue external2021-01-01 → 2021-06-30¥6.7bn
—segment totalrevenue intersegment2021-01-01 → 2021-06-30¥6m
—segment totalsegment profit2021-01-01 → 2021-06-30¥567m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 537
ItemContextValueUnit
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Current fiscal year start dateFilingDateInstant2022-01-01
Current period end dateFilingDateInstant2022-06-30
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2022-12-31
Previous fiscal year start dateFilingDateInstant2021-01-01
Comparative period end dateFilingDateInstant2021-06-30
Previous fiscal year end dateFilingDateInstant2021-12-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of group (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所プライム市場
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数100株
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)株式会社コッコウ
Address major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)兵庫県芦屋市六麓荘町15－５
Name major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)株式会社メディパルホールディングス
Address major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)東京都中央区八重洲２－７－15
Name major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)日本マスタートラスト信託銀行株式会社（信託口）
Address major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)東京都港区浜松町２－１１－３
Name major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)ゴールドマン　サックス　インターナショナル（常任代理人ゴールドマン・サックス証券株式会社）
Address major shareholdersCurrentQuarterInstant_No4MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)ゴールドマン・サックス・アンド・カンパニーレギュラーアカウント（常任代理人ゴールドマン・サックス証券株式会社）
Address major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)200 WEST STREET NEW YORK, NY, USA（東京都港区六本木６－10－１）
Name major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)國光　宏昌
Address major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese)兵庫県芦屋市
Name major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)エプソン販売株式会社
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)東京都新宿区新宿４－１－６
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)株式会社日本カストディ銀行（信託口）
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMember
Original text (Japanese)東京都中央区晴海１－８－12
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMember
Original text (Japanese)P.O. BOX 351 BOSTON MASSACHUSETTS 02101 U.S.A（東京都港区港南２ー１５－１）

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass